Evidence map›Paper›PMID 37199909›Full record

ReviewDiabetes therapy : research, treatment and education of diabetes and related disorders2023

Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes.

Naresh Kanumilli, Javed Butler, Konstantinos Makrilakis, Lars Rydén, Michael Vallis, Christoph Wanner, Shelley Zieroth, Ahmad Alhussein, Alice Cheng

Abstract readReview
In one paragraph

Review in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Naresh KanumilliNorthenden Group Practice, 489 Palatine Road, Northenden, Manchester, M22 4DH, UK. nkanumilli@nhs.net.
Javed ButlerUniversity of Mississippi, Oxford, MS, USA.
Konstantinos MakrilakisNational and Kapodistrian University of Athens Medical School, Athens, Greece.ORCID http://orcid.org/0000-0002-4160-0577
Lars RydénDepartment for Medicine K2, Karolinska Institutet, Stockholm, Sweden.
Michael VallisDalhousie University, Halifax, Canada.ORCID http://orcid.org/0000-0002-0165-5936
Christoph WannerUniversity Hospital Wuerzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0001-9507-5301
Shelley ZierothUniversity of Manitoba, Winnipeg, Canada.ORCID http://orcid.org/0000-0002-6145-9814
Ahmad AlhusseinBoehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.ORCID http://orcid.org/0000-0003-1000-8308
Alice ChengUniversity of Toronto Mississauga, Mississauga, Canada.ORCID http://orcid.org/0000-0003-2729-606X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes is one of the fastest-growing health emergencies of the twenty-first century, in part due to its association with cardiovascular and renal disease. Successful implementation of evidence-based guidelines for the management of patients with diabetes and pre-diabetes has been shown to improve patient outcomes by controlling risk factors for cardiovascular and renal disease. Recommendations include the early introduction of lifestyle adjustments, supported by pharmacological tools. Despite the availability of regularly updated, evidence-based guidelines, guideline implementation in clinical practice is low. As a result, people living with type 2 diabetes are not consistently receiving ideal clinical care. Improving guideline adherence has the potential to improve quality of life and longevity in patients with type 2 diabetes. This article introduces Guardians For Health, a global initiative that aims to improve guideline adherence by simplifying patient management and encouraging patient participation in the implementation of guidelines for type 2 diabetes. Guardians For Health is supported by a global community of implementers, with tools to support decision-making and quality assurance. Through achieving better guideline adherence, Guardians For Health hopes to achieve its vision to "stop early mortality by reducing cardiovascular and kidney complications in people with type 2 diabetes".

Indexed as

Cardiorenal risk reductionGuardians For HealthGuideline implementationMortalityQuality of lifeType 2 diabetes

Identifiers

PMID37199909
PMCPMC10241749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.